期刊文献+

原发性醛固酮增多症中低血钾对糖代谢的影响 被引量:6

Effect of Hypokalemia on Glucose Metabolism in Primary Hyperaldosteronism
在线阅读 下载PDF
导出
摘要 目的探讨低血钾在原发性醛固酮增多症包括肾上腺醛固酮分泌腺瘤(APA)、特发性醛固酮增多症(IHA)患者糖、胰岛素代谢中的作用。方法根据有无低血钾将178例原发性醛固酮增多症患者(APA103例、IHA75例)分为低血钾组和正常血钾组,2组均行3h口服葡萄糖耐量试验和卧立位醛固酮试验,观察血糖、胰岛素变化与血钾之间的关系。结果低血钾组血钾曲线下面积、胰岛素曲线下面积、空腹胰岛素水平均低于正常血钾组(P<0·05,P<0·01);低血钾组血糖曲线下面积、卧位醛固酮水平均高于正常血钾组(P<0·05);低血钾组糖耐量异常者为75·3%,正常血钾组为48·5%,两组比较差异具有显著性(P<0·01)。APA和IHA中代谢综合征的患病率分别为38·8%、57·3%,两者比较差异具有显著性(P<0·05)。结论低血钾是导致原发性醛固酮增多症患者中胰岛素分泌下降的可能原因之一;应警惕原发性醛固酮增多症患者合并代谢综合征的情况,并及时纠正其可能存在的代谢紊乱。 Objective To investigate the effect of potassium deficiency on glucose and insulin metabolism in primary hyperaldosteronism, including aldosterone-producing adenoma (APA) and idiopathic hyperaldosteronism (IHA). Methods Totally 178 patients who were diagnosed as primary hyperaldosteronism ( 103 patients with APA and 75 with IHA) were divided into hypokalemia group and normal potassium group according to their serum potassium levels. All patients received 3 hours of oral glucose tolerance test and aldosterone test to observe the relationship among glucose, insulin and serum potassium. Results Area under curve of serum potassium, area under curve of plasma insulin, and fasting serum insulin were significantly lower in the hypokalemia group than in the normal potassium group ( P 〈 0. 05, P 〈 0. 01 ) ; area under curve of glucose and aldosterone level were significantly higher in the hypokalemia group than in the normal potassium group ( P 〈 0. 05 ) . The prevalence of metabolic syndrome was significantly higher in IHA than in APA (57.3% vs 38.8% ; P 〈 0. 05). Conclusion Hypokalemia may play an important role in inhibiting insulin secretion in primary hyperaldosteronism.
出处 《中国医学科学院学报》 CAS CSCD 北大核心 2006年第6期745-749,共5页 Acta Academiae Medicinae Sinicae
基金 国家科技攻关计划课题(2004BA720A29)~~
关键词 低血钾 原发性醛固酮增多症 口服葡萄糖耐量试验 代谢综合征 hypokalemia primary hyperaldosteronism oral glucose tolerance test metabolic syndrome
  • 相关文献

参考文献15

  • 1Conn JW.The potassium and impaired glucose tolerance.N Engl J Med,1965,273(10):1135-1143.
  • 2Conn JW,Knoph RF,Nesbit RM.Clinical characteristics of primary aldosteronism from an analysis of 145 cases.Am J Surgery,1964,107(2):159-172.
  • 3Sindelka G,Widimsky J,Haas T,et al.Insulin action in primary hyperaldosteronism before and after surgical or pharmacological treatment.Exp Clin Endocrinol Diabetes,2000,108(1):21-25.
  • 4Widimsky J Jr,Sindelka G,Haas T,et al.Impaired insulin action in primary hyperaldosteronism.Physi Res,2000,49(2):241-244.
  • 5Litchfield WR,Dluhy RG.Primary aldosteronism.Endocrinol Metab Clin Nth Am,1995,24(7):592-612.
  • 6Torpy DJ,Bornstein SR,Taylor W,et al.Leptin levels are suppressed in primary aldosteronism.Horm Metab Res,1999,31(9):533-536.
  • 7Milliez P,Girerd X,Plouin PF,et al.Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism.J Am Coll Cardiol,2005,45(8):1243-1248.
  • 8杨文英.空腹血糖受损下限诊断切割点的建议[J].中华医学杂志,2005,85(28):1947-1950. 被引量:86
  • 9曾正陪 史轶蘩.多内分泌腺瘤病.协和内分泌和代谢学[M].北京:科学出版社,1999.1606-1621.
  • 10Fukushima M,Suzuki H,Seino Y.Insulin secretion capacity in the development from normal glucose tolerance to type 2 diabetes.Diabetes Res Clin Pract,2004,66 (Suppl 1):S37-S43.

二级参考文献30

  • 1贾伟平,潘洁敏,陈蕾,吴元民,陆俊茜,项坤三.空腹血糖受损切点变化与糖尿病及心脑血管事件风险的关系——上海华阳社区40岁以上人群的随访研究[J].中华内分泌代谢杂志,2004,20(5):392-395. 被引量:86
  • 2张波,王金平,杨文英,姜亚云,胡泽溪,萧建中,胡英华,李光伟.空腹血糖受损诊断标准下调的合理性分析[J].中华内分泌代谢杂志,2004,20(5):396-398. 被引量:37
  • 3王瑶,杨文英,杨兆军,李光伟.从心血管危险因素看空腹血糖受损切点下调[J].中华内分泌代谢杂志,2004,20(5):399-402. 被引量:25
  • 4McCance DR, Hanson RL, Charles MA, et al. Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes. BMJ, 1994, 308 :1323-1328.
  • 5Engelgau MM, Thompson TJ, William HH, et al. Comparison of fasting and 2-hour glucose and HbAlc levels for diagnosing diabetes.Diabetes Care, 1997, 20:785-791.
  • 6Finch CF, Zimmet PZ, Alberti KGMM. Determining diabetes prevalence: a rational basis for the use of fasting plasma glucose concentrations? Diabet Med, 1990, 7:603-610.
  • 7The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care, 1997, 20 : 1183-1197.
  • 8World Health Organization. Definition, diagnosis, and classification of diabetes mellitus and its complications. Report of a WHO consultation. Part 1: Diagnosis and classification of diabetes mellitus. Geneva: World Health Organization, 1999.
  • 9C, enuth S, Alberti KG, Bennett P, et al. Expert committee on the diagnosis and classification of diabetes mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care, 2003, 26 : 3160-3167.
  • 10Weyer C, Bogardus C, Pratley BE. Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance. Diabetes, 1999, 48:2197-2203.

共引文献87

同被引文献47

  • 1来成军,金讯波,于潇.腹腔镜肾上腺切除术治疗原发性醛固酮增多症合并2型糖尿病患者的临床研究[J].泌尿外科杂志(电子版),2014,6(3):33-35. 被引量:2
  • 2张旭,何华,陈忠,王少刚,李宏召,马鑫,李龙承,叶章群.腹膜后腹腔镜手术治疗原发性醛固酮增多症130例[J].中华外科杂志,2004,42(18):1093-1095. 被引量:32
  • 3周亚茹,曾正陪,张晶,童安莉,卢琳,宋爱羚,夏维波,付勇,姜艳,陈适,梁伟,茅江峰,张化冰,李伟.原发性醛固酮增多症的胰岛素抵抗及葡萄糖代谢异常[J].中华内分泌代谢杂志,2006,22(3):294-297. 被引量:27
  • 4梁伟,曾正陪,李汉忠,童安莉,卢琳,宋爱玲,姜艳,覃舒文,周亚茹,张晶,陈适.原发性醛固酮增多症患者术前术后胰岛B细胞功能变化的研究[J].中国实用内科杂志:临床前沿版,2006,26(11):1780-1783. 被引量:7
  • 5Funder JW, Carey RM, Fardella C, et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab, 2008,93:3266-3281.
  • 6Conn JW, Cohen EL, Rovner DR, et al. Normokalemic primary aldosteronism. A dectable cueable cause of curable " essential" hypertension. JAMA, 1965,193 : 200-206.
  • 7Fallo F, Federspil G, Veglio F, et al. The metabolic syndrome in primary aldosteronism. Curt Diab Rep,2008 ,8 :42-47.
  • 8Fallo F, Veglio F, Bertello C, et al. Prevalence and characteristics of the metabolic syndrome in primary aldosteronism. J Clin Endocrinol Metab, 2006,91:454-459.
  • 9Chun TY, Pratt JH. Hyperaldosteronism: a commonly occurring underlying feature of essential hypertension and the metabolic syndrome? Curt Opin Endocrinol Diabetes Obes, 2007, 14 : 210- 212.
  • 10Hiroi N, Sue M, Yoshibara A, et al. Prevalence of adrenalmasses in japanese patients with type 2 diabetes mellitus. Diabeto 1Metab Syndr 2010 ;2:71.

引证文献6

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部